Gene · 3597
Papers1,963
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 1,963
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Semi-automated approach for generation of biological networks on drug-induced cholestasis, steatosis, hepatitis, and cirrhosis. | Toxicol Res | 2022 | 35865277 | PubTator, text mining | PubMed |
| Efficacy, safety, and tolerability of lebrikizumab in adolescent patients with uncontrolled asthma (ACOUSTICS). | Clin Transl Allergy | 2022 | 35846226 | PubTator, text mining | PubMed |
| Genetic and hormonal mechanisms underlying sex-specific immune responses in tuberculosis. | Trends Immunol | 2022 | 35842266 | PubTator, text mining | PubMed |
| Interleukin 15 in Cell-Based Cancer Immunotherapy. | Int J Mol Sci | 2022 | 35806311 | PubTator, text mining | PubMed |
| TLR Signaling Pathway Gene Polymorphisms, Gene-Gene and Gene-Environment Interactions in Allergic Rhinitis. | J Inflamm Res | 2022 | 35769128 | PubTator, text mining | PubMed |
| Biological Therapy of Severe Asthma with Dupilumab, a Dual Receptor Antagonist of Interleukins 4 and 13. | Vaccines (Basel) | 2022 | 35746582 | PubTator, text mining | PubMed |
| Differentially Expressed miRNAs in Ulcerative Colitis and Crohn's Disease. | Front Immunol | 2022 | 35734163 | PubTator, text mining | PubMed |
| HDAC6 is a prognostic biomarker that mediates IL-13 expression to regulate macrophage polarization through AP-1 in oral squamous cell carcinoma. | Sci Rep | 2022 | 35732647 | PubTator, text mining | PubMed |
| Interleukin-13 promotes cellular senescence through inducing mitochondrial dysfunction in IgG4-related sialadenitis. | Int J Oral Sci | 2022 | 35718799 | PubTator, text mining | PubMed |
| Evaluation of Rhythmic Masseter Muscle Activity during Sleep and Awake in Patients with Dentofacial Deformity. | J Maxillofac Oral Surg | 2022 | 35712425 | PubTator, text mining | PubMed |
| A Computational Data Mining Strategy to Identify the Common Genetic Markers of Temporomandibular Joint Disorders and Osteoarthritis. | Glob Med Genet | 2022 | 35707787 | PubTator, text mining | PubMed |
| Managing Atopic Dermatitis with Lebrikizumab - The Evidence to Date. | Clin Cosmet Investig Dermatol | 2022 | 35702658 | PubTator, text mining | PubMed |
Narrative review on the management of moderate-severe atopic dermatitis in pediatric age of the Italian Society of Pediatric Allergology and Immunology (SIAIP), of the Italian Society of Pediatric Dermatology (SIDerP) and of the Italian Society of Pediatrics (SIP). | Ital J Pediatr | 2022 | 35701810 | PubTator, text mining | PubMed |
| Remodeling of gene regulatory networks underlying thermogenic stimuli-induced adipose beiging. | Commun Biol | 2022 | 35701601 | PubTator, text mining | PubMed |
| Nanodrugs Targeting T Cells in Tumor Therapy. | Front Immunol | 2022 | 35693776 | PubTator, text mining | PubMed |
| Baricitinib attenuates the proinflammatory phase of COVID-19 driven by lung-infiltrating monocytes. | Cell Rep | 2022 | 35688145 | PubTator, text mining | PubMed |
| Population Pharmacokinetics of Tralokinumab in Adult Subjects With Moderate to Severe Atopic Dermatitis. | Clin Pharmacol Drug Dev | 2022 | 35671038 | PubTator, text mining | PubMed |
| Deep Sequencing of Plasma Exosomal microRNA Level in Psoriasis Vulgaris Patients. | Front Med (Lausanne) | 2022 | 35665333 | PubTator, text mining | PubMed |
| IL-4/IL-13 axis as therapeutic targets in allergic rhinitis and asthma. | PeerJ | 2022 | 35663523 | PubTator, text mining | PubMed |
| An innate IL-25-ILC2-MDSC axis creates a cancer-permissive microenvironment for Apc mutation-driven intestinal tumorigenesis. | Sci Immunol | 2022 | 35658010 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3597/papers?page=22